Medline Inc. (MDLN) has a consensus analyst rating of Buy, based on 10 analysts covering the stock. Of those, 9 recommend buying, 1 recommend holding, and 0 recommend selling.
The analyst consensus price target for MDLN is $48.59, representing a +1.9% upside from the current price of $47.67. Price targets range from a low of $38.00 to a high of $56.00.
